AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2011
Sep 8, 2011
30016_dirs_2011-09-08_501b1562-5369-4c72-bba0-81e35daec443.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2011-09-07
Reporting Person: AYERS JONATHAN W (Director, CHAIRMAN, PRESIDENT & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-09-07 | Common Stock | M | 20000 | $12.6 | Acquired | 312618 | Direct |
| 2011-09-07 | Common Stock | S | 15000 | $76.0319 | Disposed | 297618 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-09-07 | Non-Qualified Stock Option (right to buy) | $12.60 | M | 20000 | Disposed | 2012-01-28 | Common Stock (20000) | Direct |
Footnotes
F1: The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/03/2011.
F2: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $75.63 to $76.37, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F3: Grant of options to buy shares of common stock that vest in five equal annual installments, beginning on the first anniversary date (01/28/2003) of the date of grant.